To Evaluate the Efficacy and Safety of an Defocus Lens in Slowing the Progression of Myopia (NCT06405711) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
To Evaluate the Efficacy and Safety of an Defocus Lens in Slowing the Progression of Myopia
China138 participantsStarted 2024-05
Plain-language summary
To confirm the efficacy of DIMS lenses in controlling myopia progression, we planned a prospective, single-centre, randomised, double-blind, controlled, non-inferiority clinical study.
Who can participate
Age range8 Years – 13 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* The subjects had spherical RE of -1.00 to -6.00 D, astigmatism ≤ 1.50 D, anisometropia ≤ 1.50 D
* the best corrected visual acuity in the left and right eyes subjective optometry is greater than or equal to 1.0
Exclusion Criteria:
* Candidate subjects were excluded from the study if they had strabismus, ocular limitations, or systemic abnormalities affecting vision and ocular motility